Article
PFE: Pfizer vs. Novavax: Which Vaccine Stock is a Better Buy? | StockNews.com
Rating:
0.0
Views:
120
Likes:
1
Library:
1
Pfizer Inc.(NYSE:PFE): As a large percentage of the population in the U.S has gotten vaccinated, some investors may be wary to hold onto vaccine stocks. But that may not be the case as different variants are popping up likely creating the need for booster shots. This benefits companies such as Pfizer (PFE) or Novavax (NVAX). But which is a better buy?
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value